T-Mobile reports Q1 beat, takes a bite into Verizon, AT&T >>> READ MORE


3 Huge Healthcare Trends Can Fatten Your Portfolio

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities More 

AstraZeneca Probed Over Heart-Drug Trial

British drug maker AstraZeneca says the U.S. Department of Justice is investigating a clinical trial of its Brilinta heart drug. More 

Our Stock Earnings Rundown – HSY KMB DFS SHW LUV TMO AMGN

A big week for earnings and dividend increases includes these 8 stocks in our portfolio. More 

Roche’s Breast Cancer Drug Approval Is Just the Beginning

It might have been dismissed as irrelevant by most investors, but Roche and its Perjeta could reshape the breast cancer drug landscape. More 

2 Major Pharmaceutical Rivals to Share Drug Data

AstraZeneca and Roche will share drug research data with a third company to build a compound library to accelerate drug development and lower costs. More 

Study: New Bird Flu Resistant to Roche’s Tamiflu

Physicians in China have noted that some patients with bird flu are not responding to treatment with Tamiflu, the only known drug used to fight the infection. More 

India Drops Patent Bomb on Novartis

India's ruling on a Novartis patent draws a clear line of favor between generic drug companies and Big Pharma. More